n-methyl-3,4-methylenedioxyamphetamine has been researched along with Panic Disorder in 8 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaplan, K | 1 |
Kurtz, F | 1 |
Serafini, K | 1 |
Soar, K | 1 |
Parrott, AC | 1 |
Fox, HC | 1 |
McGuire, PK | 1 |
Cope, H | 1 |
Fahy, TA | 1 |
Windhaber, J | 1 |
Maierhofer, D | 1 |
Dantendorfer, K | 1 |
Kuntze, MF | 1 |
Pennings, EJ | 1 |
Konijn, KZ | 1 |
de Wolff, FA | 1 |
Pallanti, S | 1 |
Mazzi, D | 1 |
McCann, UD | 1 |
Ricaurte, GA | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Panic Disorder
Article | Year |
---|---|
[Clinical and toxicologic aspects of the use of Ecstasy].
Topics: Animals; Axons; Brain Chemistry; Depression; Female; Fever; Humans; Impulsive Behavior; Inappropriat | 1998 |
7 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Panic Disorder
Article | Year |
---|---|
Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report.
Topics: Adult; Anxiety Disorders; Behavior Therapy; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxy | 2018 |
Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Erectile Dysfunction; Follow-Up Studies; H | 2004 |
Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
Topics: Adolescent; Adult; Cross-Sectional Studies; Delusions; England; Female; Hallucinations; Humans; Inci | 1994 |
Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine.
Topics: Adult; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Panic Disorder; Paroxeti | 1998 |
[Ecstasy and social pension: lost for life at 20 years of age?--Behavioral therapy of an anxiety disorder].
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Disability Evaluation; Female; Foll | 1998 |
MDMA (Ecstasy) precipitation of panic disorder.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxa | 1992 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |